The global molecular diagnostics for STDs market was valued at USD 3.82 billion in 2024 and is expected to reach USD 7.85 billion by 2034, expanding at a CAGR of 7.5% during the forecast period. Molecular diagnostics leverage nucleic acid amplification tests (NAATs), polymerase chain reaction (PCR), real-time PCR, and other advanced molecular...